← Leaderboards
Leslie Amass
Friends Research Institute, Inc.
$3,372,370
Attributed
$3,372,370
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,372,370 · 2
By mechanism
R01$3,372,370 · 2
Top collaborators
No co-investigators on record.
Most similar at Friends Research Institute, Inc.
Same institution · by research overlap
- Richard A Rawson$6,306,636
- Sean M. Murphy$8,373,847
- Alice Huber$1,555,157
- Barry S Brown$3,530,183
- Timothy W Kinlock$10,085,018
Others in their field
Top investigators on “Behavioral /Social Science Research Tag”
- Willard Cates · Family Health International$73,520,657
- Norman Wolmark · Nsabp Foundation, Inc.$67,161,981
- Robert J Willis · University Of Michigan At Ann Arbor$64,770,100
- Stephen A Spector · University Of California, San Diego$59,875,103
- Lloyd D Johnston · University Of Michigan At Ann Arbor$33,778,046
- Gregory H Reaman · National Childhood Cancer Foundation$29,150,052
Research focus
Behavioral /Social Science Research TagHuman SubjectClinical ResearchReinforcerHuman Therapy EvaluationHuman Pregnant SubjectCounselingPatient Care ManagementDrug Abuse TherapyOutpatient CareMethadoneTherapy ComplianceSmoking CessationHealth Services Research TagAlcoholism /Alcohol Abuse PreventionHigh Risk Behavior /LifestyleHomosexualsHomelessInterviewMaleHealth BehaviorFunctional AbilityDrug Abuse PreventionCommunity Health Services
Grant awards (8)
VOUCHER-BASED INCENTIVES IN A PREVENTION SETTING$451,055
R01 · FY2005 · DA
CONTINGENCY MANAGEMENT FOR REAL-LIFE DRUG TREATMENT$498,762
R01 · FY2004 · DA
VOUCHER-BASED INCENTIVES IN A PREVENTION SETTING$428,835
R01 · FY2004 · DA
VOUCHER-BASED INCENTIVES IN A PREVENTION SETTING$65,450
R01 · FY2004 · DA
CONTINGENCY MANAGEMENT FOR REAL-LIFE DRUG TREATMENT$487,385
R01 · FY2003 · DA
CONTINGENCY MANAGEMENT FOR REAL-LIFE DRUG TREATMENT$484,249
R01 · FY2002 · DA
CONTINGENCY MANAGEMENT FOR REAL-LIFE DRUG TREATMENT$463,300
R01 · FY2001 · DA
CONTINGENCY MANAGEMENT FOR REAL-LIFE DRUG TREATMENT$493,334
R01 · FY2000 · DA